About
Ccbio develops synthetic biology-based therapeutics that precisely engineer and edit the human microbiome to treat microbiome-related diseases, utilizing a proprietary drug discovery platform called Zeus.
Explore Ccbio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.